The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San ...

Prasad was an outspoken critic of vaccines, lockdowns and mask mandates during the Covid pandemic. In 2022, Prasad and Makary ...

He has also criticized the decision to approve the shots for children, even though recent research has found the vaccines ...

Shares of Sarepta Therapeutics cratered on Wednesday after the biopharmaceutical company trimmed its full-year forecast for ...

The Food and Drug Administration (FDA) has named Indian American hematologist-oncologist Dr. Vinay Prasad, an outspoken ...

Indian stock market closed higher on Wednesday, recovering from earlier losses despite heightened geopolitical tensions ...

Vinay Prasad, a skeptic of mainstream medicine, is now a top FDA official. Change is coming for some drugmakers, one way or ...

Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.

By Sukriti Gupta and Nikhil Sharma (Reuters) -European shares ended lower on Wednesday, pausing after weeks of strong gains, ...

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but will take place amid newly imposed scrutiny of COVID shots.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...